Novo Nordisk halves US price of Ozempic - Financial Times
8/18/2025
Novo Nordisk halves US price of Ozempic Financial TimesNovo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients CNBCGoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month Yahoo FinanceNovo Halves Ozempic Price to $499 a Month for Those Paying Cash Bloomberg.comGoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic Business Wire...
Original
Categories: Financial | Stock
Tags: a | access | after | announces | deal | drug | financial | for | half | month | offers | ozempic | price | sell | stock | the | times | to | u.s. | us | with